The use off dipept idyl peptidase-4 inhibitors in patients with type 2 diabetes & chronic kidney disease

摘要

There is a need for treatment options in patients with type 2 diabetes mellitus and kidney disease to achieve glucose targets without risk of hypoglycemia. This article describes management options for these patients using glucose lowering therapies, in particular dipeptidyl peptidase-4 inhibitors.